Literature DB >> 1987366

Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant.

A Zurbriggen1, M Yamada, C Thomas, R S Fujinami.   

Abstract

The Daniels strain of Theiler's murine encephalomyelitis produces a chronic disease which is an animal model for human demyelinating disorders. Previously, we selected a neutralization-resistant virus variant producing an altered and diminished central nervous system disease in immunocompetent mice which was evident during the later stage of infection (after 4 weeks) (A. Zurbriggen and R. S. Fujinami, J. Virol. 63:1505-1513, 1989). The exact epitope determining neurovirulence was precisely mapped to a capsid protein, VP-1, and represents a neutralizing region (A. Zurbriggen, J. M. Hogle, and R. S. Fujinami, J. Exp. Med. 170:2037-2049, 1989). Here, we present experiments with immunoincompetent animals to determine viral replication, spread, and targeting to the central nervous system in the absence of detectable antibodies or functional T cells. Nude mice were infected orally, and the virus was monitored by plaque assay, immunohistochemistry, and in situ hybridization. Early during the infection (1 week), the variant virus induced an acute disease comparable to that induced by the wild-type virus in these nude mice. Alterations in tropism in the central nervous system were not apparent when wild-type parental Daniels strain virus was compared with the variant virus. Moreover, variant virus replicated in tissue culture (BHK-21 cells) to similarly high titers in a time course identical to that of the wild-type virus (A. Zurbriggen and R. S. Fujinami, J. Virol. 63:1505-1513, 1989). However, replication of the variant virus versus the wild-type virus within the spinal cord of athymic nude mice infected per os was substantially restricted by 6 weeks postinfection. Therefore, the reduced neurovirulence in the later stage (6 weeks) of the disease is most likely due to a diminished growth rate or spread of the variant virus in the central nervous system rather than to marked differences in viral tropism.

Entities:  

Mesh:

Year:  1991        PMID: 1987366      PMCID: PMC239852     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Distribution of Theiler's virus in the CNS of athymic nude mice: effect of varying the route of inoculation.

Authors:  S Love
Journal:  J Neurol Sci       Date:  1987-10       Impact factor: 3.181

2.  Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus.

Authors:  E Cash; M Chamorro; M Brahic
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

3.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Mechanism of Theiler's virus-induced demyelination in nude mice.

Authors:  A Rosenthal; R S Fujinami; P W Lampert
Journal:  Lab Invest       Date:  1986-05       Impact factor: 5.662

6.  Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.

Authors:  H L Lipton; J Kratochvil; P Sethi; M C Dal Canto
Journal:  Neurology       Date:  1984-08       Impact factor: 9.910

7.  Quantitation, with a new assay, of Theiler's virus capsid protein in the central nervous system of mice.

Authors:  E Cash; M Chamorro; M Brahic
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

8.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

9.  Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.

Authors:  M G Murray; J Bradley; X F Yang; E Wimmer; E G Moss; V R Racaniello
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

10.  Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.

Authors:  N La Monica; W J Kupsky; V R Racaniello
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

View more
  10 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  A three-nucleotide insertion in the H stem-loop of the 5' untranslated region of Theiler's virus attenuates neurovirulence.

Authors:  P K Bandyopadhyay; A Pritchard; K Jensen; H L Lipton
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

3.  A single amino acid change determines persistence of a chimeric Theiler's virus.

Authors:  N Jarousse; R A Grant; J M Hogle; L Zhang; A Senkowski; R P Roos; T Michiels; M Brahic; A McAllister
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence.

Authors:  S B Stein; L Zhang; R P Roos
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.

Authors:  Karima Jnaoui; Muriel Minet; Thomas Michiels
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.

Authors:  P Borrow; C J Welsh; A A Nash
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

8.  Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line.

Authors:  X Lin; S Sato; A K Patick; L R Pease; R P Roos; M Rodriguez
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.

Authors:  L Fiette; C Aubert; U Müller; S Huang; M Aguet; M Brahic; J F Bureau
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

Review 10.  Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease?

Authors:  G J Atkins; I M Balluz; G M Glasgow; M J Mabruk; V A Natale; J M Smyth; B J Sheahan
Journal:  Neuropathol Appl Neurobiol       Date:  1994-04       Impact factor: 8.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.